Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study

已完结 20 由 hezhi 发布于 2026/11/3 16:29:53

DOI:DOI: 10.1016/S1470-2045(25)00480-2
文献类型：期刊论文
补充材料：仅需补充材料
文献链接：https://doi.org/10.1016/s1470-2045(25)00480-2

Elsevier

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyA Biomimetic Bifunctional Composite Enabling Integrated Thermal Protection and Insulation for Ultra-High-Temperature TPS